Literature DB >> 18273692

Prolactin and systemic malignancies: a close association.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18273692     DOI: 10.1007/s10689-008-9185-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


× No keyword cloud information.
  9 in total

1.  Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

Authors:  D Melck; L De Petrocellis; P Orlando; T Bisogno; C Laezza; M Bifulco; V Di Marzo
Journal:  Endocrinology       Date:  2000-01       Impact factor: 4.736

Review 2.  Therapeutic potential of S179D prolactin--from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulator.

Authors:  Ameae M Walker
Journal:  Expert Opin Investig Drugs       Date:  2006-10       Impact factor: 6.206

3.  Prolactin promotes growth of a spontaneous T cell lymphoma: role of tumor and host derived cytokines.

Authors:  Mahendra Pal Singh; Himanshu Sharma; Sukh Mahendra Singh
Journal:  Cancer Invest       Date:  2006-10       Impact factor: 2.176

4.  Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells.

Authors:  M A Leff; D J Buckley; J S Krumenacker; J C Reed; T Miyashita; A R Buckley
Journal:  Endocrinology       Date:  1996-12       Impact factor: 4.736

5.  Possible role of tyrosine kinases in the prolactin stimulation of cell division in Nb2 node lymphoma cells.

Authors:  G Fan; P Carbajo; J A Rillema
Journal:  Horm Metab Res       Date:  1993-05       Impact factor: 2.936

6.  S179D prolactin sensitizes human prostate cancer cells such that physiological concentrations of 1, 25 dihydroxy vitamin D3 result in growth inhibition and cell death.

Authors:  Wei Wu; Laura Zanello; Ameae M Walker
Journal:  Prostate       Date:  2007-10-01       Impact factor: 4.104

7.  Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.

Authors:  Ayush Dagvadorj; Sean Collins; Jean-Baptiste Jomain; Junaid Abdulghani; James Karras; Tobias Zellweger; Hongzhen Li; Martti Nurmi; Kalle Alanen; Tuomas Mirtti; Tapio Visakorpi; Lukas Bubendorf; Vincent Goffin; Marja T Nevalainen
Journal:  Endocrinology       Date:  2007-04-05       Impact factor: 4.736

8.  Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk.

Authors:  Maria Hietala; Håkan Olsson; Helena Jernström
Journal:  Fam Cancer       Date:  2007-12-15       Impact factor: 2.375

9.  Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression of human prolactin in blast cells of a patient of subtype M4.

Authors:  S J Hatfill; R Kirby; M Hanley; E Rybicki; L Böhm
Journal:  Leuk Res       Date:  1990       Impact factor: 3.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.